Suthanthiran M
Rogosin Institute, Immunogenetics and Transplantation Center, New York, NY 10021.
J Exp Med. 1990 Jun 1;171(6):1965-79. doi: 10.1084/jem.171.6.1965.
Transmembrane signaling of normal human T cells was explored with mAbs directed at TCR, CD2, CD4, CD5, or CD8 antigens and highly purified CD4+ T cells and CD8+ T cells. Our experiments explicitly show that: (a) crosslinkage of TCR with the CD2 antigen, and not independent crosslinking of TCR and of CD2 antigen or crosslinking of either protein with the CD4 or CD8 antigen induces significant proliferation independent of co-stimulatory signals (e.g., accessory cells, recombinant lymphokines, or tumor promoter), (b) F(ab')2 fragments of mAb directed at the TCR and F(ab')2 anti-CD2, crosslinked with F(ab')2 fragments of rabbit anti-mouse IgG, promote the proliferation of highly purified T cells, (c) a prompt and sustained increase in intracellular free Ca2+ concentration results from crosslinkage of TCR with the CD2 antigen, (d) T cell proliferation induced by this novel approach is curtailed by EGTA and by direct or competitive inhibitors of PKC, (e) crosslinkage of TCR with the CD2 antigen results in the transcriptional activation and translation of the gene for IL-2 and in the expression of IL-2 receptor alpha (CD25), (f) anti-CD25 mAbs inhibit T cell proliferation initiated by crosslinkage of TCR with the CD2 antigen, and recombinant IL-2 restores the proliferative response. Our first demonstration that crosslinkage of TCR with the CD2 antigen induces proliferation of normal human CD4+ T cells and CD8+ T cells, in addition to revealing a novel activation mechanism utilizable by the two major subsets of T cells, suggest that the CD2 antigen might be targeted for the regulation of antigen-specific T cell immunity (e.g., organ transplantation).
利用针对TCR、CD2、CD4、CD5或CD8抗原的单克隆抗体以及高度纯化的CD4⁺ T细胞和CD8⁺ T细胞,对正常人T细胞的跨膜信号传导进行了研究。我们的实验明确表明:(a) TCR与CD2抗原交联,而非TCR和CD2抗原的独立交联或任一蛋白质与CD4或CD8抗原的交联,可诱导显著增殖,且不依赖共刺激信号(如辅助细胞、重组淋巴因子或肿瘤启动子);(b) 针对TCR的单克隆抗体的F(ab')₂片段和抗CD2的F(ab')₂片段,与兔抗小鼠IgG的F(ab')₂片段交联,可促进高度纯化的T细胞增殖;(c) TCR与CD2抗原交联导致细胞内游离Ca²⁺浓度迅速且持续升高;(d) 这种新方法诱导的T细胞增殖受到EGTA以及PKC的直接或竞争性抑制剂的抑制;(e) TCR与CD2抗原交联导致IL-2基因的转录激活和翻译以及IL-2受体α(CD25)的表达;(f) 抗CD25单克隆抗体抑制由TCR与CD2抗原交联引发的T细胞增殖,而重组IL-2可恢复增殖反应。我们首次证明TCR与CD2抗原交联可诱导正常人CD4⁺ T细胞和CD8⁺ T细胞增殖,这除了揭示T细胞两个主要亚群可利用的一种新激活机制外,还表明CD2抗原可能成为调节抗原特异性T细胞免疫(如器官移植)的靶点。